<< Предыдущая

стр. 5
(из 5 стр.)

ОГЛАВЛЕНИЕ

25. Cello, J. P.. Acquired immunodeficiency syndrome
268. J. AIDS 24 (2000), 337–43.
cholangiopathy: spectrum of disease. Am. J. Med. 86 (1989),
11. Leoung, G. S., Stanford, J. F., Giordano, M. F. et al. 539–46.
Trimethoprim-sulfamethoxazole (TMP–SMX) dose escalation
versus direct rechallenge for Pneumocystis carinii pneumonia




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид
13
Профилактика оппортунистических инфекций



26. Holmberg, S. D.,Moorman, A. C., Von, Bargen, J. C., et al. 42. Frenkel, L. D., Gaur, S., Tsolia, M. et al. Cytomegalovirus
Possible effectiveness of clarithromycin and rifabutin for infection in children with AIDS. Rev. Infect. Dis. 12: Supp. 7
cryptosporidiosis chemoprophylaxis in HIV disease. J. Am. Med. (1990), S820–6.
Assoc. 279 (1998), 384–6. 43. Nigro, G., Krzystofiak, A., Gattinara, G. et al. Rapid progression
27. Gutman, L. T., Moye, J., Zimmer, B. & Tian, C. Tuberculosis in of HIV diseases in children with CMV DNAemia. AIDS 10
human immunodeficiency virus-exposed or infected United (1996), 1127–33.
States children. Pediatr. Infect. Dis. J. 13 (1994), 963–8. 44. Mussi-Pinhata, M. M., Yamamoto, Y., Figueiredo, L. T. M., et
28. Inderlied, C. B., Kemper, C. A. & Bermudez, L. E. M. The al. Congenital and perinatal cytomegalovirus infection in infants
Mycobacteriumaviumcomplex.Clin.Micro.Rev.6(1993),266–310. born to mothers infected with human immunodeficiency virus. J.
Pediatr. 132 (1998), 285–90.
29. Hoyt, L., Oleske, J., Holland, B. & Connor, E. Nontuberculous
mycobacteria in children with acquired immunodeficiency 45. Kovacs, A., Schlucter, M., Easley, K. et al. Cytomegalovirus
syndrome. Pediatr. Infect. Dis. J. 11 (1992), 354–60. infection and HIV-1 disease progression in infants born to HIV-
1-infected women. New Engl. J. Med. 341 (1999), 77–84.
30. Rutstein, R. M., Cobb, P.,McGowan, K. L. et al.Mycobacterium
avium intracellulare complex infection in HIV-infected children. 46. Spector, S. A.,McKinley,G.F., Lalezari, J.P. et al.Oral
AIDS 7 (1993), 507–12. ganciclovir for the prevention of cytomegalovirus disease in
persons with AIDS. NewEngl. J.Med. 334 (1996), 1491–7.
31. Horsburgh, C. R. Jr, Caldwell, M. B. & Simons, R. J.
Epidemiology of disseminated nontuberculousmycobacterial 47. Centers for Disease Control and Prevention. Pregnancy
disease in children with acquired immunodeficiency syndrome. outcomes following systemic prenatal acyclovir exposure – June
Pediatr. Infect. Dis. J. 12 (1993), 219–22. 1, 1984–June 30, 1993. MMWR 42 (1993), 806–9.
32. Lindegren, M. L., Hanson, C., Saletan, S. et al.Mycobacterium 48. Levin, M. J., Gershon, A. A., Weinberg, A. et al. Immunization
avium complex (MAC) in children with AIDS, United States: of HIV-infected children with varicella vaccine. J. Pediatr. 139
needfor specific prophylaxis guidelines for childrenless than 6 (2001), 305–10.
years old. Programand Abstracts of the 11th International 49. Centers for Disease Control and Prevention. Prevention of
Conference on AIDS (July 7–12, 1996, Vancouver,Canada). Varicella: updated recommendations of the Advisory Committee
Abstract no.We.B.420. on Immunization Practices (ACIP). MMWR 48 : RR-6 (1999),
33. Nightingale, S. D., Camaron, D. W., Gordin, F. M., et al. Two 1–5.
controlled trials of rifabutin prophylaxis against mycobacterium 50. Centers for Disease Control and Prevention. Prevention of
avium complex infection in AIDS. New Engl. J. Med. 329 varicella: recommendations of the Advisory Committee on Im-
(1993), 828–33. munization Practices (ACIP). MMWR 45 : RR-11 (1996), 20–4.
34. Pierce, M., Crampton, S., Henry, D. et al. A randomized trial of 51. Plancoulaine, S., Abel, L., van Beveren, M. et al. Human
clarithromycin as prophylaxis against disseminated herpesvirus 8 transmission from mother to child and between
Mycobacterium avium complex infection in patients with siblings in an endemic population. Lancet 356 (2000), 1062– 5.
advanced acquired immunodeficiency syndrome. New Engl.
52. Yeung, L. T. F., King, S. M. & Roberts, E. A. Mother-toinfant
J.Med. 335 (1996), 384–91.
transmission of hepatitis c virus. Hepatology 34 (2001), 223–9.
35. Havlir, D. V., Dube, M. P., Sattler, F. R. et al. Prophylaxis
against disseminated Mycobacterium avium complex with
weekly azithromycin, daily rifabutin, or both. New Engl. J. Med.
335 (1996), 392–8.
36. Havlir, D. V., Dube, M. P., Sattler, F. R. et al. Prophylaxis
against disseminated Mycobacterium avium complex with
weekly azithromycin, daily rifabutin, or both. New Engl. J. Med.
335 (1996), 392–8.
37. Centers for Disease Control and Prevention. Guidelines for
using antiretroviral agents among HIV-infected adults and
adolescents: recommendations of the Panel on Clinical Practices
for Treatment of HIV. MMWR 51 : RR-7 (2002), 1–56. 38.
Centers for Disease Control and Prevention. Updated guidelines
for the use of rifabutin or rifampin for the treatment and
prevention of tuberculosis among HIV-infected patients taking
protease inhibitors or nonnucleoside reverse transcriptase
inhibitors. MMWR 49 (2000), 185–9.
39. NICHD IVIG Study Group. Intravenous immune globulin for
the prevention of bacterial infection in children with
symptomatic human immunodeficiency virus infection.
NewEngl. J.Med. 325 (1991), 73–80.
40. Spector, S. A., Gelber, R. D., McGrath, N. et al. A Controlled
trial of intravenous immune globulin for the prevention of
serious bacterial infections in children receiving zidovudine for
advanced human immunodeficiency virus infection. New Engl.
J.Med. 331 (1994), 1181–7.
41. McKinsey, D. S., Wheat, L. F., Cloud, G. A., et al. Itraconazole
prophylaxis for fungal infections in patients with
advancedhumanimmunodeficiencyvirus infection: randomized,
placebo-controlled, double-blind study. Clin. Infect.Dis. 28
(1999), 1049–56.




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид

<< Предыдущая

стр. 5
(из 5 стр.)

ОГЛАВЛЕНИЕ